Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 212,468,112 papers from all fields of science
Search
Sign In
Create Free Account
GW406381X
Known as:
GW406381
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Pyrazoles
Pyridazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Biomarker exposure–response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX‐2 inhibitor
A. Taneja
,
S. Oosterholt
,
M. Danhof
,
O. Della Pasqua
Journal of clinical pharmacology
2016
Corpus ID: 46174567
An exposure–response model was used to characterize the pharmacokinetic‐pharmacodynamic relationship of GW406381, a COX‐2…
Expand
2009
2009
A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
S. Shackelford
,
R. Rauck
,
S. Quessy
,
D. Blum
,
R. Hodge
,
R. Philipson
Journal of Pain
2009
Corpus ID: 36704937
2009
2009
A Randomized, Controlled, Dose-ranging Study Investigating Single Doses of GW406381, Naproxen Sodium, or Placebo in Patients With Acute Pain After Third Molar Tooth Extraction
J. Varner
,
M. Lomax
,
D. Blum
,
S. Quessy
The Clinical Journal of Pain
2009
Corpus ID: 205454569
ObjectivesTo evaluate the efficacy and tolerability of 4 doses of GW406381, a cyclooxygenase-2 inhibitor, compared with placebo…
Expand
2008
2008
Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies.
D. Boswell
,
K. Ostergaard
,
+4 authors
S. Quessy
Medscape journal of medicine
2008
Corpus ID: 22579363
CONTEXT GW406381 is an investigational, highly selective cyclooxygenase-2 (COX-2) inhibitor that is effective in animal models of…
Expand
2008
2008
A double‐blind, randomized, placebo‐controlled, single‐dose study of the cyclooxygenase‐2 inhibitor, GW406381, as a treatment for acute migraine
A. Wentz
,
T. Jimenez
,
R. M. Dixon
,
S. Aurora
,
M. Gold
European Journal of Neurology
2008
Corpus ID: 205579968
The objective of the present study was to explore the clinical efficacy and tolerability of GW406381, a cyclooxygenase‐2 (COX‐2…
Expand
2007
2007
GW406381, a novel COX-2 inhibitor, attenuates spontaneous ectopic discharge in sural nerves of rats following chronic constriction injury
F. Zhao
,
D. Spanswick
,
Jo C. Martindale
,
A. Reeve
,
I. Chessell
Pain
2007
Corpus ID: 24223028
Highly Cited
2005
Highly Cited
2005
The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization
S. Bingham
,
P. Beswick
,
+20 authors
Joanne O Wiseman
Journal of Pharmacology and Experimental…
2005
Corpus ID: 14774002
The pathogenic form of the cyclooxygenase (COX) enzyme, COX-2, is also constitutively present in the spinal cord and has been…
Expand
2004
2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors.
P. Beswick
,
S. Bingham
,
+21 authors
Joanne O Wiseman
Bioorganic & Medicinal Chemistry Letters
2004
Corpus ID: 21124544
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE